Luis Gil Abinader, @abinader.bsky.social (@abinader) 's Twitter Profile
Luis Gil Abinader, @abinader.bsky.social

@abinader

Global health law, intellectual property, access to medicine.

ID: 16857253

calendar_today19-10-2008 22:38:07

9,9K Tweet

1,1K Followers

1,1K Following

Lina Khan (@linamkhan) 's Twitter Profile Photo

1. One way pharma companies block competition and inflate the cost of medicines is by filing bogus patent listings. Today FTC challenged over 300 junk patent listings, including for blockbuster weight-loss & type 2 diabetes drugs Ozempic and Victoza. ftc.gov/news-events/ne…

Health Justice Initiative - HJI (@healthjusticein) 's Twitter Profile Photo

Breaking:⏰📢 'Groundbreaking Access to Documents Show Pharma Giants Bullied SA in Covid-19 Vaccine Negotiations' Records & Analysis “The Negotiations, One Sided-Part 2’’ with Public Citizen O'Neill Institute is publicly available at: healthjusticeinitiative.org.za/pandemic-trans… @peoplesvaccine

Breaking:⏰📢

'Groundbreaking Access to Documents Show Pharma Giants Bullied SA in Covid-19 Vaccine Negotiations'

Records &amp; Analysis “The Negotiations, One Sided-Part 2’’ with <a href="/Public_Citizen/">Public Citizen</a> <a href="/oneillinstitute/">O'Neill Institute</a> is publicly available at:
healthjusticeinitiative.org.za/pandemic-trans…

@peoplesvaccine
Matthew Kavanagh matthewkavanagh@bsky.social (@mmkavanagh) 's Twitter Profile Photo

Today we join Health Justice Initiative - HJI in report showing Moderna & Pfizer wielded unprecedented power in COVID-19 negotiations w South Africa. The SA govt tried to include transparency, supply commitment, etc to realize its obligations under SA and Intl law. Was blocked by monopoly power

Luis Gil Abinader, @abinader.bsky.social (@abinader) 's Twitter Profile Photo

Interesting to see South African government officials citing the WHA transparency resolution to advocate against secrecy during their negotiations with Pfizer. International norms can either deprive or empower government officials with more leverage to protect public interests.

Interesting to see South African government officials citing the WHA transparency resolution to advocate against secrecy during their negotiations with Pfizer. 

International norms can either deprive or empower government officials with more leverage to protect public interests.
Health Policy Watch - Global Health News Reporting (@healthpolicyw) 's Twitter Profile Photo

.Moderna tried to extract a huge price for its #COVID-19 #vaccine from the South African government at the height of the pandemic, according to the local NGO Health Justice Initiative - HJI, in revelations made public this week. ✍ Kerry Cullinan healthpolicy-watch.news/modernas-attem…

Nina Schwalbe (@nschwalbe) 's Twitter Profile Photo

📰The US is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine. 💉It would be good to understand what, if any, access provisions are included in this deal. Important Financial Times story. Thanks for breaking it Oliver Barnes.

📰The US is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine.

💉It would be good to understand what, if any, access provisions are included in this deal. 

Important <a href="/FT/">Financial Times</a>  story. Thanks for breaking it <a href="/mroliverbarnes/">Oliver Barnes</a>.
Chris Morten (@cmorten2) 's Twitter Profile Photo

Students in my clinic—the Science, Health & Information Clinic Columbia Law School—represented EFF in this motion, as part of a long-running partnership to protect the public's right to access evidence & arguments in patent & other "tech law" cases. Next stop: the Federal Circuit!

Tahir Amin (@realtahiramin) 's Twitter Profile Photo

Mylan’s legal fees for patent litigation: 2012: $46,158,403 2013: $38,211,911 2014: $38,618,993 If you want to launch a generic or biosimilar, be prepared to sink tens of millions of $ into legal fees to cut through patent thickets.

Mylan’s legal fees for patent litigation:

2012: $46,158,403
2013: $38,211,911
2014: $38,618,993

If you want to launch a generic or biosimilar, be prepared to sink tens of millions of $ into legal fees to cut through patent thickets.
MedicinesPatentPool (@medspatentpool) 's Twitter Profile Photo

👉MPP’s Expert Advisory Group meet in Geneva to provide critical guidance on our work. This group of experts in regulatory, IP law, public health, R&D, and more play a vital role in helping expand access to essential medicines worldwide. 🌍💊#AccessToMedicines

👉MPP’s Expert Advisory Group meet in Geneva to provide critical guidance on our work. This group of experts in regulatory, IP law, public health, R&amp;D, and more play a vital role in helping expand access to essential medicines worldwide. 🌍💊#AccessToMedicines
Matthew Kavanagh matthewkavanagh@bsky.social (@mmkavanagh) 's Twitter Profile Photo

New on #USAID: First, in Foreign Policy our piece on illegality of abolishing USAID. To be clear-eyed: This is neither good policy nor legal under the most basic elements of U.S. law and the Constitution. w Luis Gil Abinader, @abinader.bsky.social And you can also read our memo... foreignpolicy.com/2025/02/04/usa…

Nina Schwalbe (@nschwalbe) 's Twitter Profile Photo

🛑Closing down USAID is illegal. 📜It's an independent agency with authorities legislated by Congress. ⚠️The president has no legal authority to abolish or move it under the State Department unilaterally Strong analysis by Matthew Kavanagh [email protected] & Luis Gil Abinader, @abinader.bsky.social. 👇🏼 bit.ly/4i2jeAH

🛑Closing down USAID is illegal.

📜It's an independent agency with authorities legislated by Congress.

⚠️The president has no legal authority to abolish or move it under the State Department unilaterally 

Strong analysis by <a href="/MMKavanagh/">Matthew Kavanagh matthewkavanagh@bsky.social</a> &amp; <a href="/abinader/">Luis Gil Abinader, @abinader.bsky.social</a>. 
👇🏼
bit.ly/4i2jeAH